Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRH Study in Hypopituitarism
NCT04902235Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jul 2021
- Primary completion
- Apr 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of corticorelin ovine triflutate in hypopituitarism, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Jul 2021; status: completed.
02
Drugs
corticorelin ovine triflutate
03
Conditions
hypopituitarism
Beyond the preview
Go deeper on NCT04902235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04902235.